List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 156 studies with search of: Abacavir OR Ziagen[TREATMENT] AND HIV [CONDITION]
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Completed KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks
Conditions: HIV Infection;   Infection, Human Immunodeficiency Virus
Interventions: Drug: LEXIVA (GW433908);   Drug: Ritonavir;   Drug: KALETRA;   Drug: EPIVIR;   Drug: Ziagen;   Drug: Abacavir/Lamivudine;   Drug: Fosamprenavir
2 Completed A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced Patients
Conditions: Infection, Human Immunodeficiency Virus I;   HIV Infection
Interventions: Drug: abacavir/lamivudine;   Drug: abacavir;   Drug: lamivudine
3 Unknown † Raltegravir Switch for Toxicity or Adverse Events
Conditions: HIV/AIDS;   Antiretroviral Therapy;   HIV Infections
Interventions: Drug: tenofovir emtricitabine raltegravir;   Drug: Lamivudine Abacavir Raltegravir;   Drug: Abacavir free
4 Completed Comparison of Abacavir Following Once-Daily And Twice-Daily Administration In HIV Infected Subjects
Condition: HIV Infection
Intervention: Drug: abacavir
5 Unknown † Effectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) in HIV Patients Who Have Never Received Treatment
Condition: HIV Infections
Interventions: Drug: Ritonavir;   Drug: Abacavir sulfate;   Drug: Amprenavir;   Drug: Efavirenz;   Drug: Lamivudine;   Drug: Stavudine
6 Completed
Has Results 		Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection
Conditions: Infection, Human Immunodeficiency Virus I;   HIV Infection
Interventions: Drug: Abacavir (ABC)/lamivudine (3TC) + atazanavir (ATV) + ritonavir (/r);   Drug: Abacavir (ABC)/lamivudine (3TC) + atazanavir (ATV)
7 Completed
Has Results 		Abacavir/Lamivudine Versus Emtricitabine/Tenofovir Both In Combination With Lopinavir/Ritonavir For The Treatment Of HIV
Condition: HIV Infection
Interventions: Drug: emtricitabine/tenofovir;   Drug: abacavir/lamivudine
8 Completed A Study Comparing Safety Of Abacavir And Lamivudine Administered Once-Daily As A Single Tablet Versus The Same Drugs Administered Twice-Daily As Separate Tablets (ALOHA Study)
Condition: HIV Infection
Intervention: Drug: Abacavir/Lamivudine
9 Completed A Study of the Safety and Effectiveness of Combination Anti-HIV Therapy in HIV-Infected Adults
Condition: HIV Infections
Interventions: Drug: Abacavir sulfate, Lamivudine and Zidovudine;   Drug: Lamivudine/Zidovudine;   Drug: Abacavir sulfate;   Drug: Efavirenz
10 Unknown † Four-Drug Combination Therapy With Zidovudine, Lamivudine, 1592U89 (Abacavir), and 141W94 (Amprenavir) in HIV-Infected Patients
Condition: HIV Infections
Interventions: Drug: Abacavir sulfate;   Drug: Amprenavir;   Drug: Lamivudine;   Drug: Zidovudine
11 Completed Study to Evaluate Changes in CD4 on Replacing TDF With ABC or DDI+TDF With ABC+3TC
Condition: HIV Infections
Interventions: Drug: Abacavir;   Drug: Didanosine;   Drug: Abacavir+Lamivudine
12 Unknown † Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir)
Condition: HIV Infections
Interventions: Drug: Abacavir sulfate, Lamivudine and Zidovudine;   Drug: Lamivudine/Zidovudine;   Drug: Abacavir sulfate
13 Completed Relative Bioavailability Study of Two New Dolutegravir/Abacavir/Lamivudine Fixed Dose Combination Tablets
Conditions: Healthy Subjects;   Infection, Human Immunodeficiency Virus
Interventions: Drug: Dolutegravir 50 mg/abacavir 600 mg/lamivudine 300 mg;   Drug: Dolutegravir 50 mg;   Drug: abacavir 600 mg/lamivudine 300 mg
14 Completed Antiretroviral Treatment Simplification Study With Efavirenz + Abacavir + 3TC Once Daily
Condition: HIV Infections
Interventions: Drug: efavirenz;   Drug: Abacavir+lamivudine
15 Completed Clinical Utility Of Genetic Screening For HLA-B*5701, On Susceptibility To Abacavir Hypersensitivity
Condition: HIV Infection
Intervention: Drug: Abacavir
16 Recruiting ZIAGEN® Post-marketing Surveillance
Condition: Infection, Human Immunodeficiency Virus I
Intervention: Drug: ZIAGEN®
17 Unknown † A Study to Test the Safety, Tolerance, and Metabolism of Abacavir (1592U89, ABC) With Standard Zidovudine (ZDV) Therapy in Newborn Infants Born to HIV-1 Infected Women
Condition: HIV Infections
Interventions: Drug: Abacavir sulfate;   Drug: Zidovudine
18 Completed Blood Levels of Abacavir After One Dose in HIV-Infected Children and Adolescents
Condition: HIV Infections
Intervention: Drug: Abacavir sulfate
19 Completed Efficacy and Safety of Switching From Retrovir to Tenofovir or Abacavir in HIV-infected Patients
Condition: HIV Infections
Interventions: Drug: Tenofovir disoproxil fumarate;   Drug: Abacavir
20 Completed Viral Dynamics and Pharmacokinetics of Abacavir and Tenofovir
Condition: HIV Infections
Interventions: Drug: Tenofovir;   Drug: Abacavir

Previous Page Studies Shown (1-20) Next Page (21-40)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services